Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Woolsey Pharmaceuticals Completes Patient Recruitment for High-Dose Cohort of ALS Study
Details : Bravyl (fasudil) is a small molecule inhibitor of the rho-associated kinase (ROCK), being evaluated for the treatment of amyotrophic lateral sclerosis.
Product Name : Bravyl
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 12, 2024
Woolsey Pharmaceuticals Treats First ALS Patient with Higher-Dose BRAVYL in REAL Study
Details : Bravyl (fasudil) is a small molecule inhibitor of the rho-associated kinase (ROCK), given orally, is being evaluated for the treatment of amyotrophic lateral sclerosis.
Product Name : Bravyl
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 08, 2024
Raya Therapeutic Announces Supportive Clinical Results of Fasudil (RT1968) in ALS Patients
Details : RT1968 (fasudil) is a small molecule inhibitor of the rho-associated kinase (ROCK), being evaluated for the treatment of amyotrophic lateral sclerosis.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
June 17, 2024
Rho Kinase Inhibitor in Amyotrophic Lateral Sclerosis (REAL)
Details : Fasudil is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Amyotrophic Lateral Sclerosis.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
February 01, 2022
Fasudil fOr redUcing elopemeNt and Spatial Disorientation
Details : Fasudil is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Dementia.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
March 11, 2021
Rho Kinase (ROCK) Inhibitor in Tauopathies - 1
Details : Fasudil is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Supranuclear Palsy, Progressive.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
February 02, 2021